Literature DB >> 35048244

Psoriasis and uveitis.

Büşra Köse1, Dilek Uzlu2, Hidayet Erdöl2.   

Abstract

PURPOSE: Psoriasis, which is a chronic, immune-mediated skin disease of unknown etiology, not only affects the skin, but also is linked to many systemic conditions such as arthritis, cardiovascular disease, depression, and malignancy. Although many types of eye involvement are encountered in psoriasis patients, dry eye is the first among them. Uveitis is an entity that can be associated with psoriasis and can cause severe vision loss as a result of late diagnosis, inadequate and inappropriate treatment. In this review, we aimed to shed light on the diagnosis, type, prognosis and treatment of uveitis in psoriasis patients by compiling current datas obtained from published studies and to guide the follow-up and treatment of these patients.
METHODS: A systematic literature search was done on PubMed using key words including "psoriasis", "psoriatic arthritis", "uveitis", "TNF- inhibitors", "HLA B27".
RESULTS: In the literature, the frequency, type and treatment of uveitis developing in the course of psoriatic arthritis are clearly defined. However, the coexistence of psoriasis and uveitis has not yet been clarified due to few numbers published studies and designs of these studies. Since we examined the existing studies, we determined that the coexistence of psoriasis and uveitis could be acute or insidious, and the probability and severity of uveitis increased as the severity of skin and joint involvement increased. In addition, we found that psoriasis-associated uveitis can be bilateral, chronic, severe progression and with a high recurrence rate.
CONCLUSION: The relations between non-arthritic psoriasis and uveitis have not yet been fully elucidated. Physicians who treat these diseases must be cautious, and refer their patients who have psoriasis to an ophthalmologist for periodic examination, even if they do not have eye symptoms. On the other hand, ophthalmologists must be careful in uveitis patients in terms of skin and joint involvement, and must not overlook the underlying disease.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  HLA B27; Psoriasis; Psoriatic arthritis; TNF-α inhibitors; Uveitis

Mesh:

Substances:

Year:  2022        PMID: 35048244     DOI: 10.1007/s10792-022-02225-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  53 in total

Review 1.  Psoriasis.

Authors:  Frank O Nestle; Daniel H Kaplan; Jonathan Barker
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

2.  Factors associated with increased aqueous flare in psoriasis.

Authors:  F Okamoto; Y Umebayasi; F Ohtsuka; S Hommura
Journal:  Jpn J Ophthalmol       Date:  2001 Mar-Apr       Impact factor: 2.447

Review 3.  Ocular changes in patients with psoriasis.

Authors:  Zdravka Demerdjieva; Iskra Mazhdrakova; Nikolai Tsankov
Journal:  Clin Dermatol       Date:  2019-07-31       Impact factor: 3.541

Review 4.  Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.

Authors:  Craig A Elmets; Craig L Leonardi; Dawn M R Davis; Joel M Gelfand; Jason Lichten; Nehal N Mehta; April W Armstrong; Cody Connor; Kelly M Cordoro; Boni E Elewski; Kenneth B Gordon; Alice B Gottlieb; Daniel H Kaplan; Arthur Kavanaugh; Dario Kivelevitch; Matthew Kiselica; Neil J Korman; Daniela Kroshinsky; Mark Lebwohl; Henry W Lim; Amy S Paller; Sylvia L Parra; Arun L Pathy; Elizabeth Farley Prater; Reena Rupani; Michael Siegel; Benjamin Stoff; Bruce E Strober; Emily B Wong; Jashin J Wu; Vidhya Hariharan; Alan Menter
Journal:  J Am Acad Dermatol       Date:  2019-02-13       Impact factor: 11.527

5.  Psoriasis beyond the skin surface: a pilot study on the ocular involvement.

Authors:  A Campanati; P Neri; K Giuliodori; I Arapi; G Carbonari; E Borioni; C P Herbort; C Mariotti; A Giovannini; A Offidani
Journal:  Int Ophthalmol       Date:  2014-05-06       Impact factor: 2.031

Review 6.  Ocular psoriasis.

Authors:  Balvinder Rehal; Bobeck S Modjtahedi; Lawrence S Morse; Ivan R Schwab; Howard I Maibach
Journal:  J Am Acad Dermatol       Date:  2011-05-06       Impact factor: 11.527

7.  The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis.

Authors:  Megan Lam; Jeremy Steen; Justin Di Lu; Ronald Vender
Journal:  J Cutan Med Surg       Date:  2020-08-31       Impact factor: 2.092

8.  Biologic response modifier therapy for psoriatic ocular inflammatory disease.

Authors:  Nancy Huynh; Rene A Cervantes-Castaneda; Pooja Bhat; Michael J Gallagher; C Stephen Foster
Journal:  Ocul Immunol Inflamm       Date:  2008 May-Jun       Impact factor: 3.070

9.  Ocular findings in patients with psoriasis.

Authors:  Berna Kilic; Umit Dogan; Ali Haydar Parlak; Nadir Goksugur; Mualla Polat; Didem Serin; Sedat Ozmen
Journal:  Int J Dermatol       Date:  2013-01-20       Impact factor: 2.736

10.  Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.

Authors:  Miguel Cordero-Coma; Fahd Anzaar; Lucia Sobrin; C Stephen Foster
Journal:  Ocul Immunol Inflamm       Date:  2007 Mar-Apr       Impact factor: 3.070

View more
  2 in total

1.  Psoriasis and medical ramifications: A comprehensive analysis based on observational meta-analyses.

Authors:  Yun Zhou; Lixian Zhong; Lianli Shen; Sisi Chen; Qiuting Zeng; Leizhen Lai; Shaohui Tang
Journal:  Front Med (Lausanne)       Date:  2022-08-29

2.  Uveitis and nail psoriasis in a patient without articular involvement: a case report.

Authors:  Juan Sebastián Pineda-Sierra; Luisa Fernanda Peña-Pulgar; Carlos Cifuentes-González; William Rojas-Carabali; Alejandra de-la-Torre
Journal:  BMC Ophthalmol       Date:  2022-09-24       Impact factor: 2.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.